FX.co ★ Forex-Nachrichten und Ereignisse. Review und Analyse der wirtschaftlichen Ereignisse
typeContent_19130
typeContent_19130:::
EHang And Chongqing Changan Automobile Partner On Flying Car Innovations
EHang Holdings Limited (EH), a prominent Urban Air Mobility technology platform company, announced on Saturday that it has entered into a strategic cooperation agreement with Chongqing Changan Automobile...
typeContent_19130:::
Qualcomm Wins Jury Verdict Upholding Innovation And ARM Contract
Qualcomm (QCOM) has expressed contentment with today's decision, emphasizing that the jury's verdict upholds its right to innovate. This ruling confirms that all Qualcomm products implicated in the case...
typeContent_19130:::
Volkswagen And Union Agree To Job Cuts Of Over 35,000 By 2030
Volkswagen Group (VKW.L, VLKAF.PK, VOW.BE) has reached a consensus with its union to responsibly reduce its workforce by over 35,000 employees across its German operations by 2030. This decision...
typeContent_19130:::
FDA Approves Lilly's Zepbound To Treat Obstructive Sleep Apnea In Adults With Obesity
The U.S. Food and Drug Administration has granted approval for Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults suffering from obesity. This medication...
typeContent_19130:::
TSX Snaps 6-day Losing Streak, Ends 0.76% Up
On Friday, the Canadian stock market rebounded, ending a six-day downward trend, thanks to optimism stemming from U.S. Commerce Department data. The report revealed the PCE price index's growth...
typeContent_19130:::
Expion360 CFO Greg Aydelott Resigns
Expion360 Inc. (XPON) has announced that Greg Aydelott, the company's Chief Financial Officer, will be stepping down effective December 31, 2024, due to family health reasons. Aydelott has pledged...
typeContent_19130:::
Vertex' Trikafta Gets Expanded FDA Approval For Cystic Fibrosis Treatment
Vertex Pharmaceuticals (VRTX) announced on Friday that the U.S. Food and Drug Administration (FDA) has broadened its approval of a cystic fibrosis medication to include additional patients with varying mutation...
typeContent_19130:::
Vertex's Cystic Fibrosis Drug Alyftrek Gets FDA Approval
Vertex Pharmaceuticals Inc. (VRTX) announced on Friday that the U.S. Food and Drug Administration (FDA) has approved Alyftrek for the treatment of cystic fibrosis. Alyftrek is a cutting-edge, once-daily triple...
typeContent_19130:::
Tesla Recalls Nearly 700,000 Vehicles Over Tire Pressure Monitoring System Issue
Tesla Inc. (TSLA) has announced a recall affecting approximately 700,000 vehicles due to an issue with the tire pressure monitoring light. The recall targets specific models, including the 2024 Cybertruck...
typeContent_19130:::
U.S. Stocks Show Strong Move To The Upside Following Inflation Data
Following a relatively unchanged session, Friday witnessed a significant upward trajectory in the stock market. Initially displaying some weakness, the major averages rebounded, gaining solid footing in positive territory...
